Complete Revascularization in Patients With STEMI and MVD: CV Outcomes, Quality of Life, and Future Directions
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Consultant Fee/Honoraria/Speaker’s Bureau - J&J; Novartis
- Grant Support/Research Contract - Sanofi-Aventis; Abbott